Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Vijeepallam, Kamini, Vijayapandi Pandy, Thubasni Kunasegaran, Dharmani D. Murugan, and Murali Naidu. "Mitragyna speciosa leaf extract exhibits antipsychotic-like effect with the potential to alleviate positive and negative symptoms of psychosis in mice." Frontiers in pharmacology 7 (2016): 464. |
|
Morrissette, Debbi A., and Stephen M. Stahl. "Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment." CNS spectrums 17, no. s1 (2012): 10-21. |
|
Gallagher III, Bernard J., and Brian J. Jones. "Early-onset schizophrenia: Symptoms and social class of origin." International Journal of Social Psychiatry 63, no. 6 (2017): 492-497. |
|
Miettunen, Jouko, Johanna Immonen, John J. McGrath, Matti Isohanni, and Erika Jääskeläinen. "The age of onset of schizophrenia spectrum disorders." In Age of onset of mental disorders, pp. 55-73. Springer, Cham, 2019. |
|
Miller, Brian J., Prianka Kandhal, Mark Hyman Rapaport, Andrew Mellor, and Peter Buckley. "Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses." Brain, behavior, and immunity 45 (2015): 28-35. |
|
Yüksel, Rabia Nazik, Irem Ekmekci Ertek, Asiye U?ra? Dikmen, and Erol Göka. "High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters." Nordic journal of psychiatry 72, no. 5 (2018): 336-340. |
|
Ces, Aurelia, David Reiss, Ondine Walter, Jürgen Wichmann, Eric P. Prinssen, Brigitte L. Kieffer, and Abdel-Mouttalib Ouagazzal. "Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists." Neuropsychopharmacology 37, no. 2 (2012): 378-389. |
|
Nielsen, Philip Rising, Esben Agerbo, Kristin Skogstrand, David Michael Hougaard, Urs Meyer, and Preben Bo Mortensen. "Neonatal levels of inflammatory markers and later risk of schizophrenia." Biological psychiatry 77, no. 6 (2015): 548-555. |
|
Basu, Dipannita, Jessica M. Castellano, Nancy Thomas, and Ram K. Mishra. "Cell?free protein synthesis and purification of human dopamine D2 receptor long isoform." Biotechnology progress 29, no. 3 (2013): 601-608. |
|
Tishler, Todd A., George Bartzokis, Po H. Lu, Erika P. Raven, Mher Khanoyan, Chandra J. Kirkpatrick, Meghan H. Pyle et al. "Abnormal trajectory of intracortical myelination in schizophrenia implicates white matter in disease pathophysiology and the therapeutic mechanism of action of antipsychotics." Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 3, no. 5 (2018): 454-462. |
|
Torrey, E. Fuller, and Robert H. Yolken. "Schizophrenia and infections: the eyes have it." Schizophrenia bulletin 43, no. 2 (2017): 247-252. |
|
Ve?gner, La?szlo?, A?gnes Peragovics, La?szlo? Tombor, Bala?zs Jelinek, Pa?l Czobor, Andreas Bender, Zolta?n Simon, and Andra?s Ma?lna?si-Csizmadia. "Experimental confirmation of new drug–target interactions predicted by drug profile matching." Journal of medicinal chemistry 56, no. 21 (2013): 8377-8388. |
|
YILDIZ, Mustafa. "?izofreni ve ?ki Uçlu Bozuklu?un Tedavisinde Ruhsal Toplumsal ?yile?tirim Çal??malar?." Archives of Neuropsychiatry/Noropsikiatri Arsivi 58 (2021). |
|
Liu, Z. W., J. L. Liu, Y. An, L. Zhang, and Y. M. Wang. "Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations." Genetics and Molecular Research 11, no. 1 (2012): 261-270. |
|
Gardiner, Erin, Adam Carroll, Paul A. Tooney, and Murray J. Cairns. "Antipsychotic drug-associated gene–miRNA interaction in T-lymphocytes." International Journal of Neuropsychopharmacology 17, no. 6 (2014): 929-943. |
|
Yildiz, Mustafa. "Psychosocial Rehabilitation Interventions in the Treatment of Schizophrenia and Bipolar Disorder." Archives of Neuropsychiatry 58, no. Suppl 1 (2021): S77. |
|
Loprinzi, Paul D. "Frequency of moderate-to-vigorous physical activity (MVPA) is a greater predictor of systemic inflammation than total weekly volume of MVPA: Implications for physical activity promotion." Physiology & behavior 141 (2015): 46-50. |
|
Bordia, Tanuja, Danhui Zhang, Xiomara A. Perez, and Maryka Quik. "Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia." Experimental neurology 286 (2016): 32-39. |
|
Karageorgiou, Vasilios, Gerasimos P. Milas, and Ioannis Michopoulos. "Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis." Schizophrenia research 206 (2019): 4-12. |
|
Rampino, Antonio, Rosa M. Falcone, Arianna Giannuzzi, Rita Masellis, Linda A. Antonucci, and Silvia Torretta. "Strategies for Psychiatric Rehabilitation and their Cognitive Outcomes in Schizophrenia: Review of Last Five-year Studies." Clinical Practice & Epidemiology in Mental Health 17, no. 1 (2021). |
|